Please enable JavaScript.
Coggle requires JavaScript to display documents.
NASH, Alcohol, Other Hepatitides - Coggle Diagram
NASH, Alcohol, Other Hepatitides
Fibrosis
-
Tests for fibrosis
Fibroscan, Blood tests, Liver Biopsy
Acetaminophen Toxicity
-
Treatment
-
-
-
24 hours: Cosnider GI decontamination, APAP levels, and Continue AC
-
NAFLD
Risk Factors
Obesity, Type 2 DM, Hypertriglyceridemia, Metabolic syndrome
Suspected Risk Factors
Hypothyroidism, Hypopituitaryism, Hypogonadism, OSA, Polycystic ovarian syndrome, excess fructose, sudden weight loss
Pathogenesiss
Increase in FFA -> Increase in triglycerides or Hyperinsulinemia or Hyperglycemia leads to beta oxidation -> Increase FFA and increased triglycerides
NASH
Symptoms
Often asymptomatic, nonspecific symptoms
Diagnosis
Mildly elevated ALT, Steatosis on ultrasound, Presence of steatosis, ballooning and lobular inflammation on biopsy (often diagnosis of exclusion)
Tests
Blood based tests, methods to assess physical properties, imaging
-
NAFLD Fibrosis: Age, AST, ALT, Platelet, GMI, Albumin, Impaired fasting glucose/diabetes
-
NAFLD
Diagnosis
Consider biopsy if at risk of advanced fibrosis (diabetes, obese, Age >50, AST/ALT >1)
-
Cholestatic Disease
PSC
-
-
-
-
-
Natural History of PSC
Colitis -> Biliary inflammation -> Biliary Fibrosis -> Portal hypertension -> Variceal bleeding -> Liver-related Death/Liver transplantation
-